We have demonstrated that the WNT5A antagonistic peptide Box-5 (a t-butyloxycarbonyl-modified WNT5A-derived hexapeptide) caused a significant inhibition of WNT5A-stimulated A2058 melanoma cell migration [76]. The gene discussed is WNT5A; the disease is melanoma.